Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas

Cited by (1,002)

Items 601–700 of 1,002

1. Return to work following diagnosis of low-grade glioma
   Isabelle Rydén, Louise Carstam, Sasha Gulati, Anja Smits, Katharina Stibrant Sunnerhagen, Per Hellström, Roger Henriksson, Jiri Jr Bartek, Øyvind Olav Salvesen, Asgeir Store Jakola · 2020 · Neurology
2. LINC00152 Promotes Invasion through a 3′-Hairpin Structure and Associates with Prognosis in Glioblastoma
   Brian J. Reon, Bruno Takao Real Karia, Manjari Kiran, Anindya Dutta · 2018 · Molecular Cancer Research
3. Next-Generation in vivo Modeling of Human Cancers
   Gaetano Gargiulo · 2018 · Frontiers in Oncology
4. Genomic analysis of primary and recurrent gliomas reveals clinical outcome related molecular features
   Longbo Zhang, Zhiqiang Liu, Jin Li, Tianxiang Huang, Ying Xiang Wang, Lianpeng Chang, Wenjie Zheng, Yujie Ma, Fenghua Chen, Xuan Gong et al. · 2019 · Scientific Reports
5. Toward a standard pathological and molecular characterization of recurrent glioma in adults: a Response Assessment in Neuro-Oncology effort
   Ali S. Haider, Martin J. van den Bent, Patrick Yung Wen, Michael A. Vogelbaum, Susan Marina Chang, Peter Canoll, Craig Horbinski, Jason T. Huse · 2019 · Neuro-Oncology
6. 3-O-Acetyl-11-keto- -boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma
   Wan Li, Liwen Ren, Xiangjin Zheng, Jinyi Liu, Jinhua Wang, Tengfei Ji, Guanhua Du · 2020 · Acta Pharmaceutica Sinica B
7. Classification of diffuse lower‐grade glioma based on immunological profiling
   Fan Wu, Zhiliang Wang, Kuan‐Yu Wang, Guanzhang Li, Ruichao Chai, Yuqing Liu, Haoyu Jiang, You Zhai, Yuemei Feng, Zheng Zhao et al. · 2020 · Molecular Oncology
8. DAXX-ATRX regulation of p53 chromatin binding and DNA damage response
   Nitish Gulve, Chenhe Su, Zhong Deng, Samantha S. Soldan, Olga V. Vladimirova, Jayamanna M. Wickramasinghe, Hongwu Zheng, Andrew V. Kossenkov, Paul M. Lieberman · 2022 · Nature Communications
9. DNA Methylation and Histone Modification in Low-Grade Gliomas: Current Understanding and Potential Clinical Targets
   Ahmad Ozair, Vivek Bhat, Reid S. Alisch, Atulya Aman Khosla, Rupesh R Kotecha, Yazmín Odia, Michael William McDermott, Manmeet Singh Ahluwalia · 2023 · Cancers
10. Molecular classification of adult diffuse gliomas: conflicting IDH1/IDH2, ATRX, and 1p/19q results
    Leomar Y. Ballester, Jason T. Huse, Guilin Tang, Gregory N. Fuller · 2017 · Human Pathology
11. Capicua regulates neural stem cell proliferation and lineage specification through control of Ets factors
    Shiekh Tanveer Ahmad, Alexandra D. Rogers, Myra J. Chen, Rajiv Dixit, Lata Adnani, Luke Frankiw, Samuel O. Lawn, Michael D. Blough, Mana M. Alshehri, Wei Wu et al. · 2019 · Nature Communications
12. Glioblastoma Multiforme and Genetic Mutations: The Issue Is Not Over Yet. An Overview of the Current Literature
    Nicola Montemurro · 2019 · Journal of Neurological Surgery Part A Central European Neurosurgery
13. Approximate Graph Laplacians for Multimodal Data Clustering
    Aparajita Khan, Pradipta Maji · 2019 · IEEE Transactions on Pattern Analysis and Machine Intelligence
14. Intratumoral Susceptibility Signals Reflect Biomarker Status in Gliomas
    Ling-Wei Kong, Jin Chen, Heng Zhao, Kun Yao, Shengyu Fang, Zheng Wang, Yinyan Wang, Shou-Wei Li · 2019 · Scientific Reports
15. Analyzing magnetic resonance imaging data from glioma patients using deep learning
    Bjoern H. Menze, Fabian Isensee, Roland Wiest, Benedikt Wiestler, Klaus Hermann Maier-Hein, Mauricio Reyes, Spyridon Bakas · 2020 · Computerized Medical Imaging and Graphics
16. MRI Features May Predict Molecular Features of Glioblastoma in Isocitrate Dehydrogenase Wild-Type Lower-Grade Gliomas
    Chae Jung Park, Kyunghwa Han, Hwiyoung Kim, Sung Soo Ahn, Dongmin Choi, Yae Won Park, Jong Hee Chang, Se Hoon Kim, Soonmee Cha, Seung‐Koo Lee · 2021 · American Journal of Neuroradiology
17. Modelling MR and clinical features in grade II/III astrocytomas to predict IDH mutation status
    Harpreet Hyare, Louise Rice, Stefanie Catherine Thust, Parashkev Nachev, Ashwani Jha, Marina Milić, Sebastian Brandner, Jeremy H. Rees · 2019 · European Journal of Radiology
18. Dissecting Molecular Features of Gliomas: Genetic Loci and Validated Biomarkers
    Antonietta Arcella, Fiona Limanaqi, Rosangela Ferese, Francesca Biagioni, Maria Antonietta Oliva, Marianna Storto, Mirco Fanelli, Stefano Gambardella, Francesco Fornai · 2020 · International Journal of Molecular Sciences
19. Prognostic significance of ARL9 and its methylation in low-grade glioma
    Yutang Tan, Suojun Zhang, Qungen Xiao, Junwen Wang, Kai Zhao, Weihua Liu, Kuan Huang, Weidong Tian, Hongquan Niu, Ting Lei et al. · 2020 · Genomics
20. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma
    Jiajie Lu, Yuecheng Peng, Rihong Huang, Zejia Feng, Yongyang Fan, Haojian Wang, Zhaorong Zeng, Yunxiang Ji, Yezhong Wang, Zhaotao Wang · 2021 · BMC Cancer
21. PANoptosis in cancer, the triangle of cell death
    Hantao Cai, Mingming Lv, Tingting Wang · 2023 · Cancer Medicine
22. Small molecule inhibitors targeting m6A regulators
    Guotai Feng, Yongya Wu, Yuan Hu, Shuai Wen, Xiao Jun Yang, Yong Li, Liang Ouyang, Guan Wang · 2024 · Journal of Hematology & Oncology
23. Recent Advances on the Molecular Pathology of Glial Neoplasms in Children and Adults
    Fausto J. Rodríguez, M. Adelita Vizcaíno, Ming‐Tseh Lin · 2016 · Journal of Molecular Diagnostics
24. Sex difference of mutation clonality in diffuse glioma evolution
    Hongyi Zhang, Jianlong Liao, Xinxin Zhang, Erjie Zhao, Xin Liang, Shangyi Luo, Jian Shi, Fulong Yu, Jinyuan Xu, Weitao Shen et al. · 2018 · Neuro-Oncology
25. Extent of resection, molecular signature, and survival in 1p19q-codeleted gliomas
    Andrew L. A. Garton, Connor Jarrett Kinslow, Ali I. Rae, Amol M. Mehta, Susan C. Pannullo, Rajiv Magge, Rohan R. Ramakrishna, Guy M. McKhann, Michael B. Sisti, Jeffrey N. Bruce et al. · 2020 · Journal of neurosurgery
26. Splicing is an alternate oncogenic pathway activation mechanism in glioma
    Robert Siddaway, Scott Milos, Arun Kumaran Anguraj Vadivel, Tara Dobson, Jyothishmathi Swaminathan, Scott T. Ryall, Sanja Pajovic, Palak G. Patel, Javad Nazarian, Oren Josh Becher et al. · 2022 · Nature Communications
27. Increased HOXA5 expression provides a selective advantage for gain of whole chromosome 7 in IDH wild-type glioblastoma
    Patrick Joseph Cimino, Youngmi Kim, Hua‐Jun Wu, Jes Alexander, Hans‐Georg Wirsching, Frank Szulzewsky, Kenneth L. Pitter, Tatsuya Ozawa, Jiguang Wang, Julio Vazquez et al. · 2018 · Genes & Development
28. Prediction of isocitrate dehydrogenase genotype in brain gliomas with MRI: single-shell versus multishell diffusion models
    Figini, Matteo, Riva, Marco, Graham, Mark, Castelli, Gian Marco, Fernandes, Bethania, Grimaldi, Marco, Baselli, Giuseppe, Pessina, Federico, Bello, Lorenzo, Zhang, Hui et al. · 2018 · Radiology
29. Deep learning for image analysis: Personalizing medicine closer to the point of care
    Quin Yuhui Xie, Kevin Faust, Randy Van Ommeren, Adeel Sheikh, Ugljesa Djuric, Phedias Diamandis · 2019 · Critical Reviews in Clinical Laboratory Sciences
30. The Predictive Value of Monocytes in Immune Microenvironment and Prognosis of Glioma Patients Based on Machine Learning
    Nan Zhang, Ziyu Dai, Wantao Wu, Zeyu Wang, Hui Cao, Yakun Zhang, Zhanchao Wang, Hao Zhang, Quan Cheng · 2021 · Frontiers in Immunology
31. Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice Guideline
    Lia Moriguchi Halasz, Albert A. Attia, Lisa Bradfield, Daniel Jay Brat, John P. Kirkpatrick, Nadia N. Issa Laack, Nafisha Lalani, Emily S. Lebow, Arthur K. Liu, Heather M. Niemeier et al. · 2022 · Practical Radiation Oncology
32. Revealing the role of SPP1+ macrophages in glioma prognosis and therapeutic targeting by investigating tumor-associated macrophage landscape in grade 2 and 3 gliomas
    Wenshu Tang, Cario W.S. Lo, Wei Ma, Annie Tsz-Wai Chu, Amy H.Y. Tong, Brian Hon‐Yin Chung · 2024 · Cell & Bioscience
33. ccmGDB: a database for cancer cell metabolism genes
    Pora Kim, Feixiong Cheng, Junfei Zhao, Zhongming Zhao · 2015 · Nucleic Acids Research
34. Systems Biology in Kidney Transplantation: The Application of Multi-Omics to a Complex Model
    Sai Vineela Bontha, Daniel G. Maluf, Thomas Mueller, Valeria R. Mas · 2016 · American Journal of Transplantation
35. Discrimination between Glioma Grades II and III Using Dynamic Susceptibility Perfusion MRI: A Meta-Analysis
    Anna Falk Delgado, Alberto F. Delgado · 2017 · American Journal of Neuroradiology
36. Distinct molecular profile of diffuse cerebellar gliomas
    Masashi Nomura, Akitake Mukasa, Genta Nagae, Shogo Yamamoto, Kenji Tatsuno, Hiroki Ueda, Shiro Fukuda, Takayoshi Umeda, Tomonari Suzuki, Ryohei Otani et al. · 2017 · Acta Neuropathologica
37. Multi-faceted computational assessment of risk and progression in oligodendroglioma implicates NOTCH and PI3K pathways
    Sameer H. Halani, Safoora Yousefi, José E. Velázquez Vega, Michael R. Rossi, Zheng Zhao, Fatemeh Amrollahi, Chad A. Holder, Amelia Baxter-Stoltzfus, Jennifer Mary Eschbacher, Brent D Griffith et al. · 2018 · npj Precision Oncology
38. The Misclassification of Diffuse Gliomas: Rates and Outcomes
    Julian Bryan Iorgulescu, Matthew Torre, Maya Harary, Timothy Richard Smith, Ayal Aaron Aizer, David A. Reardon, Jill S. Barnholtz‐Sloan, Arie Perry · 2019 · Clinical Cancer Research
39. Observation after surgery for low grade glioma: long-term outcome in the light of the 2016 WHO classification
    Elena Jansen, Christina Hamisch, Daniel F. Ruess, Dieter Henrik Heiland, Roland Goldbrunner, Maximilian Ingolf Ruge, Oliver Schnell, Stefan Grau · 2019 · Journal of Neuro-Oncology
40. T2/FLAIR-mismatch sign for noninvasive detection of IDH-mutant 1p/19q non-codeleted gliomas: validity and pathophysiology
    Martha Foltyn‐Dumitru, Karen Natalia Nieto Taborda, Ulf Neuberger, Gianluca Brugnara, Annekathrin Reinhardt, Damian Stichel, Sabine Heiland, Christel C. Herold‐Mende, Andreas Wilhelm Unterberg, Jürgen Debus et al. · 2020 · Neuro-Oncology Advances
41. Diffusion and perfusion MRI may predict EGFR amplification and the TERT promoter mutation status of IDH-wildtype lower-grade gliomas
    Yae Won Park, Sung Soo Ahn, Chae Jung Park, Kyunghwa Han, Eui Hyun Kim, Seok‐Gu Kang, Jong Hee Chang, Se Hoon Kim, Seung‐Koo Lee · 2020 · European Radiology
42. Applications of chemical exchange saturation transfer magnetic resonance imaging in identifying genetic markers in gliomas
    Shanshan Jiang, Zhibo Wen, Sung Soo Ahn, Kejia Cai, Daniel Paech, Charles G. Eberhart, Jinyuan Zhou · 2022 · NMR in Biomedicine
43. Advances in Neuro-Oncological Imaging: An Update on Diagnostic Approach to Brain Tumors
    Paniz Sabeghi, Paniz Zarand, Sina Zargham, Batis Golestany, Arya Shariat, Myles Chang, Evan Yang, Priya Rajagopalan, Daniel Phung, Ali Gholamrezanezhad · 2024 · Cancers
44. Chemotherapy for low-grade glioma
    Martin J. van den Bent · 2015 · Current Opinion in Neurology
45. Diagnostic accuracy of 2-hydroxyglutarate magnetic resonance spectroscopy in newly diagnosed brain mass and suspected recurrent gliomas
    Min Zhou, Yue Zhou, Huijun Vicky Liao, Benjamin C. Rowland, Xiangquan Kong, Nils D. Arvold, David A. Reardon, Patrick Yung Wen, Alexander Lin, Raymond Y. Huang · 2018 · Neuro-Oncology
46. Cic Loss Promotes Gliomagenesis via Aberrant Neural Stem Cell Proliferation and Differentiation
    Rui Ryan Yang, Lee H. Chen, Landon John Hansen, Austin B. Carpenter, Casey J. Moure, Heng Liu, Christopher J. Pirozzi, Bill H. Diplas, Matthew S. Waitkus, Paula K. Greer et al. · 2017 · Cancer Research
47. Transcriptomic analysis of CIC and ATXN1L reveal a functional relationship exploited by cancer
    Derek Wong, Kohl Lounsbury, Amy M. Lum, Jungeun Song, Susanna Y. Chan, Véronique Leblanc, Suganthi Chittaranjan, Marco A. Marra, Stephen S. F. Yip · 2018 · Oncogene
48. Clinical Presentation, Natural History, and Prognosis of Diffuse Low-Grade Gliomas
    Anja Smits, Asgeir Store Jakola · 2018 · Neurosurgery Clinics of North America
49. Metabolic reprogramming in the pathogenesis of glioma: Update
    Kenta Masui, Hiromi Onizuka, Webster K. Cavenee, Paul S. Mischel, Noriyuki Shibata · 2019 · Neuropathology
50. PI3K/AKT/mTOR Pathway Alterations Promote Malignant Progression and Xenograft Formation in Oligodendroglial Tumors
    Kensuke Tateishi, Taishi Nakamura, Tareq Adnan Juratli, Erik Abraham Williams, Yuko Matsushita, Shigeta Miyake, Mayuko Nishi, Julie J. Miller, Shilpa S. Tummala, Alexandria L. Fink et al. · 2019 · Clinical Cancer Research
51. Gliomas arising in the setting of Li-Fraumeni syndrome stratify into two molecular subgroups with divergent clinicopathologic features
    Emily A. Sloan, Stephanie Hilz, Rohit K. Gupta, Cathryn René Cadwell, Biswarathan Ramani, Jeffrey W. Hofmann, Cassie Kline, Anu Banerjee, Alyssa Terry Reddy, Nancy Ann Oberheim Bush et al. · 2020 · Acta Neuropathologica
52. ATRX regulates glial identity and the tumor microenvironment in IDH-mutant glioma
    Husam A. Babikir, Lin Wang, Karin Shamardani, Francisca L. Catalan, Sweta Sudhir, Manish Kumar Aghi, David Ronan Raleigh, Joanna J. Phillips, Aaron A. Diaz · 2021 · Genome biology
53. Applications of artificial intelligence in the analysis of histopathology images of gliomas: a review
    Jan-Philipp Redlich, Friedrich Feuerhake, Joachim Weis, Nadine S. Schaadt, Sarah Teuber‐Hanselmann, Christoph Buck, Sabine Luttmann, Andrea Eberle, Stefan Nikolin, Arno Appenzeller et al. · 2024 · npj Imaging
54. Genome-Wide Association Studies in Glioma
    Ben Kinnersley, Richard S. Houlston, Melissa L. Bondy · 2018 · Cancer Epidemiology Biomarkers & Prevention
55. Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond
    Anna M. Krichevsky, Erik J. Uhlmann · 2019 · Neurotherapeutics
56. Multicenter DSC–MRI-Based Radiomics Predict IDH Mutation in Gliomas
    Georgios C. Manikis, Georgios Ioannidis, Loizos C. Siakallis, Katerina Nikiforaki, Michael Iv, Diana Vozlič, Katarina Surlan-Popović, Max Wintermark, Sotirios Bisdas, Kostas Marias A · 2021 · Cancers
57. ATRX loss promotes immunosuppressive mechanisms in IDH1 mutant glioma
    Chengchen Hu, Kimberly Wang, Ceylan Damon, Yi Fu, Tengjiao Ma, Lisa E. Kratz, Bachchu Lal, Mingyao Ying, Shuli Xia, Daniel P. Cahill et al. · 2021 · Neuro-Oncology
58. Genomic and molecular features distinguish young adult cancer from later-onset cancer
    William Lee, Zishan Wang, Miriam Saffern, Tomi Wei Jun, Kuan‐lin Huang · 2021 · Cell Reports
59. Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas
    Gaia Ninatti, Martina Sollini, Beatrice Bono, Noemi Gozzi, Daniil Fedorov, Lidija Antunovic, Fabrizia Gelardi, Pierina Navarria, Letterio Salvatore Politi, Federico Pessina et al. · 2022 · Neuro-Oncology
60. Genetic Classification of Gliomas: Refining Histopathology
    Michael Bonner Foote, Nickolas Papadopoulos, Luis Alberto Diaz · 2015 · Cancer Cell
61. Evolving Molecular Genetics of Glioblastoma
    Qiu-Ju Li, Jinquan Cai, Cheng-yin Liu · 2016 · Chinese Medical Journal
62. The Effect of Molecular Diagnostics on the Treatment of Glioma
    Nancy Ann Oberheim Bush, Nicholas Arthur Butowski · 2017 · Current Oncology Reports
63. Familial melanoma-astrocytoma syndrome: synchronous diffuse astrocytoma and pleomorphic xanthoastrocytoma in a patient with germline CDKN2A/B deletion and a significant family history
    Andrew Kai-Hong Chan, Seunggu Jude Han, Winward Choy, Daniah T. Beleford, Manish Kumar Aghi, Mitchel Stuart Berger, Joseph T.C. Shieh, Andrew W. Bollen, Arie Perry, Joanna J. Phillips et al. · 2017 · Clinical Neuropathology
64. Effects of the Green Tea Polyphenol Epigallocatechin-3-Gallate on Glioma: A Critical Evaluation of the Literature
    Chung Thanh Le, William P. J. Leenders, Remco Jurriaan Molenaar, Cornelis J.F. Van Noorden · 2018 · Nutrition and Cancer
65. ADAR3 expression is an independent prognostic factor in lower-grade diffuse gliomas and positively correlated with the editing level of GRIA2Q607R
    Ying Zhang, Kuanyu Wang, Zheng Zhao, Si Sun, Kenan Zhang, Ruoyu Huang, Fan Zeng, Huimin Hu · 2018 · Cancer Cell International
66. Intelligent feature engineering and ontological mapping of brain tumour histomorphologies by deep learning
    Kevin Faust, Sudarshan Bala, Randy Van Ommeren, Alessia Portante, Raniah Al Qawahmed, Ugljesa Djuric, Phedias Diamandis · 2019 · Nature Machine Intelligence
67. A kinase-deficient NTRK2 splice variant predominates in glioma and amplifies several oncogenic signaling pathways
    Siobhan S. Pattwell, Sonali Arora, Patrick Joseph Cimino, Tatsuya Ozawa, Frank Szulzewsky, Pia Hoellerbauer, Tobias Bonifert, Benjamin G. Hoffstrom, Norman Boiani, Hamid Bolouri et al. · 2020 · Nature Communications
68. Extent of resection in diffuse low-grade gliomas and the role of tumor molecular signature—a systematic review of the literature
    Lucas Alverne Freitas de Albuquerque, João Paulo Almeida, Leonardo de Macêdo Filho, Andrei Fernandes Joaquim, Hugues Duffau · 2020 · Neurosurgical Review
69. High incidence of TERT mutation in brain tumor cell lines
    Tanner Michael Johanns, Yujie Fu, Dale K. Kobayashi, Yu Mei, Ian F. Dunn, Diane D. Mao, Albert H. Kim, Gavin P. Dunn · 2016 · Brain Tumor Pathology
70. Identification of CRKII, CFL1, CNTN1, NME2, and TKT as Novel and Frequent T-Cell Targets in Human IDH-Mutant Glioma
    Steffen Dettling, Slava Stamova, Rolf Warta, Martina Schnölzer, Carmen Rapp, Anchana Rathinasamy, David Reuß, Kolja Pocha, Saskia Roesch, Christine Jungk et al. · 2018 · Clinical Cancer Research
71. Circ-EPB41L5 regulates the host gene EPB41L5 via sponging miR-19a to repress glioblastoma tumorigenesis
    Tao� Lv, Yifeng Miao, Tianqi Xu, Wenhua Sun, Youzhou Sang, Jia Feng, Xiaohua Zhang · 2020 · Aging
72. Diagnostic performance of gliomas grading and IDH status decoding A comparison between 3D amide proton transfer APT and four diffusion‐weighted MRI models
    Hu Guo, Jun Liu, Junjiao Hu, Huiting Zhang, Wei Zhao, Min Gao, Yi Zhang, Guang Yang, Yan Cui · 2022 · Journal of Magnetic Resonance Imaging
73. Research into cancer metabolomics: Towards a clinical metamorphosis
    Orianne Olivares, J. Henry M. Däbritz, Ayala King, Eyal Gottlieb, Christina Halsey · 2015 · Seminars in Cell and Developmental Biology
74. ATRX, IDH1-R132H and Ki-67 immunohistochemistry as a classification scheme for astrocytic tumors
    Jinquan Cai, Chuanbao Zhang, Wei Zhang, Guangzhi Wang, Kun Yao, Zhiliang Wang, Guanzhang Li, Zenghui Qian, Yongli Li, Tao Jiang et al. · 2016 · Oncoscience
75. Adaptive Evolution of the GDH2 Allosteric Domain Promotes Gliomagenesis by Resolving IDH1R132H-Induced Metabolic Liabilities
    Matthew S. Waitkus, Christopher J. Pirozzi, Casey J. Moure, Bill H. Diplas, Landon John Hansen, Austin B. Carpenter, Rui Ryan Yang, Zhaohui Wang, Brian O. Ingram, Edward D. Karoly et al. · 2017 · Cancer Research
76. Tissue-specific DNA methylation loss during ageing and carcinogenesis is linked to chromosome structure, replication timing and cell division rates
    Marija Dmitrijeva, Stephan Ossowski, Luis G. Serrano, Martin H. Schaefer · 2018 · Nucleic Acids Research
77. Emerging Medical Treatments for Meningioma in the Molecular Era
    Fares Nigim, Hiroaki Wakimoto, Ekkehard Matthias Kasper, Linda P.C.M. Ackermans, Yasin Temel · 2018 · Biomedicines
78. Sensitive and rapid detection ofTERTpromoter andIDHmutations in diffuse gliomas
    Bill H. Diplas, Heng Liu, Rui Ryan Yang, Landon John Hansen, Alexis L. Zachem, Fangping Zhao, Darell D. Bigner, Roger E. McLendon, Yuchen Jiao, Yiping He et al. · 2018 · Neuro-Oncology
79. Primary central nervous system tumor treatment and survival in the United States, 2004–2015
    Catherine R. García, Stacey A. Slone, Therese A. Dolecek, Bin Huang, Janna H. Neltner, John Lee Villano · 2019 · Journal of Neuro-Oncology
80. Diffusion tensor imaging radiomics in lower-grade glioma: improving subtyping of isocitrate dehydrogenase mutation status
    Chae Jung Park, Yoon Seong Choi, Yae Won Park, Sung Soo Ahn, Seok‐Gu Kang, Jong Hee Chang, Se Hoon Kim, Seung‐Koo Lee · 2019 · Neuroradiology
81. Applications of cerebrospinal fluid circulating tumor DNA in the diagnosis of gliomas
    Zhenyu Zhao, Cheng Zhang, Mi Li, Yiping Shen, Shiyu Feng, Jialin Liu, Fangye Li, Lei Hou, Zhong Chen, Jingjing Jiang et al. · 2019 · Japanese Journal of Clinical Oncology
82. CIC is a critical regulator of neuronal differentiation
    Inah Hwang, Heng Pan, Jun Yao, Olivier Elemento, Hongwu Zheng, Jihye Paik · 2020 · JCI Insight
83. Assessment of isochromosome 12p and 12p abnormalities in germ cell tumors using fluorescence in situ hybridization, single-nucleotide polymorphism arrays, and next-generation sequencing/mate-pair sequencing
    C. Eric Freitag, William R. Sukov, Alan Haruo Bryce, Jamie V. Berg, Chad Vanderbilt, Wei Shen, James B. Smadbeck, Patricia Theresa Greipp, Rhett P. Ketterling, Robert Brian Jenkins et al. · 2021 · Human Pathology
84. Fusion detection and quantification by pseudoalignment
    Páll Melsted, Shannon L. Hateley, Isaac Joseph, Harold Pimentel, Nicolas Bray, Lior S. Pachter · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
85. Interferon-γ resistance and immune evasion in glioma develop via Notch-regulated co-evolution of malignant and immune cells
    Elena Parmigiani, Robert Ivánek, Chiara Rolando, Katrin Hafen, Gleb Turchinovich, Frank Michael Lehmann, Alexandra Gerber, Šime Brkić, Stephan Frank, Sara C. Meyer et al. · 2022 · Developmental Cell
86. Multiparametric MR radiomics in brain glioma: models comparation to predict biomarker status
    Jinlong He, Jialiang Ren, Guangming Niu, Aishi Liu, Qiong Wu, Shenghui Xie, Xueying Ma, Bo Li, Peng Wang, Jing Shen et al. · 2022 · BMC Medical Imaging
87. Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patients
    Deborah T. Blumenthal, Addie Dvir, Alexander Lossos, Tzahala Tzuk-Shina, Tzach Lior, Dror Limon, Shlomit Yust‐Katz, Alejandro Lokiec, Zvi Ram, Jeffrey S. Ross et al. · 2016 · Journal of Neuro-Oncology
88. Immature myeloid cells in the tumor microenvironment: Implications for immunotherapy
    Neha Kamran, Mayuri Chandran, Pedro Ricardo Lowenstein, Maria Graciela Castro · 2016 · Clinical Immunology
89. Intraoperative perception and estimates on extent of resection during awake glioma surgery: overcoming the learning curve
    Darryl Lau, Shawn L. Hervey‐Jumper, Seunggu Jude Han, Mitchel Stuart Berger · 2017 · Journal of neurosurgery
90. Genetic and Epigenetic Features of Rapidly Progressing IDH-Mutant Astrocytomas
    Timothy E. Richardson, Adwait Amod Sathe, Mohammed Kanchwala, Gaoxiang Jia, Amyn A. Habib, Guanghua Xiao, Matija Snuderl, Chao Xing, Kimmo J. Hatanpaa · 2018 · Journal of Neuropathology & Experimental Neurology
91. Characteristics and outcomes of elderly patients with diffuse gliomas: a multi-institutional cohort study by Kansai Molecular Diagnosis Network for CNS Tumors
    Takahiro Sasaki, Junya Fukai, Yoshinori Kodama, Takanori Hirose, Yoshiko Okita, Shusuke Moriuchi, Masahiro Nonaka, Naohiro Tsuyuguchi, Yuzo Terakawa, Takehiro Uda et al. · 2018 · Journal of Neuro-Oncology
92. Methylation-dependent Tissue Factor Suppression Contributes to the Reduced Malignancy of IDH1-mutant Gliomas
    Dusten J. Unruh, Snezana Mirkov, Brian D. Wray, Michael R. Drumm, Jonathan Balquiedra Lamano, Yuping D. Li, Qazi F. Haider, Rodrigo Javier, Kathleen McCortney, Amanda Muhs Saratsis et al. · 2018 · Clinical Cancer Research
93. Elevated signature of a gene module coexpressed with CDC20 marks genomic instability in glioma
    Yunqiu Zhang, Jiuyi Li, Kaikai Yi, Jing Feng, Zhengmin Cong, Zheng Wang, Yanfei Wei, Fan Wu, Wen Cheng, Ayaz Ali Samo et al. · 2019 · Proceedings of the National Academy of Sciences
94. Surgery for Diffuse WHO Grade II Gliomas: Volumetric Analysis of a Multicenter Retrospective Cohort From the German Study Group for Intraoperative Magnetic Resonance Imaging
    Moritz Scherer, Hajrulla Ahmeti, Constantin Roder, Florian A Gessler, Christine Jungk, Andrej Paľa, Benjamin Mayer, Christian Senft, Marcos Soares Tatagiba, Michael Synowitz et al. · 2019 · Neurosurgery
95. HGF/MET Signaling in Malignant Brain Tumors
    Elizabeth Qian Xu Mulcahy, Rossymar Rivera Colόn, Roger Abounader · 2020 · International Journal of Molecular Sciences
96. Targeting Notch to Maximize Chemotherapeutic Benefits: Rationale, Advanced Strategies, and Future Perspectives
    Nadezda Zhdanovskaya, Mariarosaria Firrincieli, Sara Lazzari, Eleonora Pace, Pietro Scribani Rossi, María Pía Felli, Claudio Talora, Isabella Screpanti, Rocco Palermo · 2021 · Cancers
97. Lentivirus-mediated silencing of HSDL2 suppresses cell proliferation in human gliomas
    Chen Ruokun, Xue Yake, Yang Fengdong, Wei Xinting, Song Laijun, Liu Xianzhi · 2016 · Tumor Biology
98. Overview of DNA methylation in adult diffuse gliomas
    Kosuke Aoki, Atsushi Natsume · 2019 · Brain Tumor Pathology
99. Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas
    Zenghui Qian, Yiming Li, Xing Fan, Chuanbao Zhang, Yinyan Wang, Tao Jiang, Xing Liu · 2017 · Journal of Neuro-Oncology
100. Pan-Cancer Comparative and Integrative Analyses of Driver Alterations Using Japanese and International Genomic Databases
     Sara Horie, Yuki Saito, Yasunori Kogure, Kota Mizuno, Yuta Ito, Mariko Tabata, Takanori Kanai∥, Koichi Murakami, Junji Koya, Keisuke Kataoka · 2024 · Cancer Discovery